國檢集團(603060.SH)擬8100萬元收購雲南合信60%股權
格隆匯11月8日丨國檢集團(603060.SH)公佈,為拓展國檢集團在西南地區的檢驗檢測業務,儘快實現國檢集團的跨地域佈局,提高市場佔有率,國檢集團於2019年11月8日召開第三屆董事會第十六次會議,審議了《關於收購雲南合信工程檢測諮詢有限公司60%股權項目的議案》,國檢集團與雲南合信股東董林(自然人)、朱祖玲(自然人)以及雲南鈞信工程檢測合夥企業(有限合夥)簽署了《關於雲南合信工程檢測諮詢有限公司的股權轉讓協議》,公司以現金8100萬元收購雲南合信60%股權。本次收購完成後,雲南合信成為國檢集團的控股子公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.